Aggressive NK-Cell Leukemia — knowledge graph · CancerIndex

Knowledge graph · Cancer

Aggressive NK-Cell Leukemia

hematologic malignancy

Identifier: CI-CAN-00001752
Entity page: /cancer/aggressive-nk-cell-leukemia ↗
Edges: 25

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Aggressive NK-Cell Leukemia investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 15
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Aggressive NK-Cell Leukemia	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants

Aggressive NK-Cell Leukemia studied in …STUDIED_INderived10 of 10
→ studied in	NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · condition mapped ALIAS · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03719105early Phase 1 · recruiting Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma · condition mapped ALIAS · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07727083recruiting Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05475925Phase 1/Phase 2 · recruiting A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05863234Phase 1/Phase 2 · recruiting Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05941156Phase 2 · unknown Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia · condition mapped ALIAS · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Aggressive NK-Cell Leukemia	1	Observed	clinicaltrials	graph →